- Published at
- by thestreet.com
positive
positive
Synairgen Announces Commencement Of Dosing In Its International Phase III Study Of Inhaled Interferon Beta In Hospitalised COVID-19 Patients
Press release
Synairgen plc ('Synairgen' or the 'Company')
Synairgen announces commencement of dosing in its international Phase III study of inhaled